Publications by authors named "Heon Jung"

As highly integrated electronic devices and automotive parts are becoming used in high-power and load-bearing systems, thermal conductivity and mechanical damping properties have become critical factors. In this study, we applied two different fillers of aluminium nitride (AlN) and boron nitride (BN), having polygonal and platelet shapes, respectively, into ethylene-propylene-diene monomer (EPDM) rubber to ensure improved thermo-mechanical properties of EPDM composites. These two different shapes are considered advantageous in providing effective pathways of phonon transfer as well as facilitating sliding movement of packed particles.

View Article and Find Full Text PDF

Nanocrystalline iron ore particles were fabricated by a wet-milling process using an Ultra Apex Mill, after which they were used as raw materials of iron-based catalysts for low-temperature Fischer-Tropsch synthesis (FTS) below 280 degrees C, which usually requires catalysts with a high surface area, a large pore volume, and a small crystallite size. The wet-milling process using the Ultra Apex Mill effectively destroyed the initial crystallite structure of the natural iron ores of several tens to hundreds of nanometers in size, resulting in the generation of nanocrystalline iron ore particles with a high surface area and a large pore volume. The iron-ore-based catalysts prepared from the nanocrystalline iron ore particles effectively catalyzed the low-temperature FTS, displaying a high CO conversion (about 90%) and good C5+ hydrocarbon productivity (about 0.

View Article and Find Full Text PDF

Fischer-Tropsch synthesis (FTS) was carried out over nanocrystalline ferrihydrite-based (Fe9O2(OH)23) catalysts activated by different reducing agents: syngas (H2+CO), CO, and H2. The syngas activation successfully changed the ferrihydrite-based catalysts into an active and stable catalytic structure with chi-carbide (Fe2.5 C) and epsilon'-carbide (Fe2.

View Article and Find Full Text PDF

Temperature-programmed reduction using H2 (H2-TPR) and CO (CO-TPR) was carried out to investigate the reduction and carburization behavior of nanocrystalline ferrihydrite-based Fe/Cu/K/SiO2 catalysts for use in Fischer-Tropsch synthesis (FTS). Unlike pure ferrihydrite, the ferrihydrite-based catalysts did not pass through the intermediate decomposition step of ferrihydrite (Fe9O2(OH)23) into hematite (a-Fe2O3) as they were reduced into magnetite (Fe3O4). This is attributed to the enhanced thermal stability induced by SiO2.

View Article and Find Full Text PDF

Using a simple thermal treatment under a CO flow, uniform micrometer-sized iron oxalate dihydrate cubes prepared by hydrothermal reaction were transformed into Fe5C2@C nanoparticles to form a mesoporous framework; the final structure was successfully applied to the high-temperature Fischer-Tropsch reaction and it showed high activity (CO conversion = 96%, FTY = 1.5 × 10(-4) molCO gFe(-1) s(-1)) and stability.

View Article and Find Full Text PDF

Background: Alzheimer's disease (AD) is pathologically characterized by excessive accumulation of amyloid-beta (Aβ) fibrils within the brain and activation of astrocytes and microglial cells. In this study, we examined anti-inflammatory and anti-amyloidogenic effects of 2,4-bis(p-hydroxyphenyl)-2-butenal (HPB242), an anti-inflammatory compound produced by the tyrosine-fructose Maillard reaction.

Methods: 12-month-old Tg2576 mice were treated with HPB242 (5 mg/kg) for 1 month and then cognitive function was assessed by the Morris water maze test and passive avoidance test.

View Article and Find Full Text PDF

Purpose: s: Although the standard management of limited stage small cell lung cancer is concurrent platinum-based chemotherapy with thoracic radiotherapy (TRT), the optimal timing of the TRT remains controversial. We investigated the feasibility of concurrent chemoradiation for the patients with limited stage small cell lung cancer after 2 cycles of combination chemotherapy with Etoposide/Cisplatin (EP).

Materials And Methods: EP consisted of Etoposide 100 mg/m2 on day 1 to 3 and Cisplatin 70 mg/m2 on day 1.

View Article and Find Full Text PDF